Know Cancer

or
forgot password

Prognostic Factors for Korean Patients With Renal Cell Carcinoma and Venous Tumor Thrombus Extension: Application of the New 2009 TNM Staging System


N/A
18 Years
N/A
Not Enrolling
Both
Carcinoma, Renal Cell, Thrombus

Thank you

Trial Information

Prognostic Factors for Korean Patients With Renal Cell Carcinoma and Venous Tumor Thrombus Extension: Application of the New 2009 TNM Staging System


Inclusion Criteria:



- age ≥ 18 years old

- patients with RCC and venous tumor thrombus who underwent radical nephrectomy and
thrombectomy

Exclusion Criteria:

- von Hippel-Lindau disease

- tuberous sclerosis syndrome

- Wilms' tumor

- synchronous bilateral tumor

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Retrospective

Outcome Measure:

Cancer-specific survival

Outcome Time Frame:

Five years

Safety Issue:

Yes

Principal Investigator

Cheol Kwak, M.D., Ph.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Seoul National University Hospital

Authority:

South Korea: Institutional Review Board

Study ID:

MCCho5

NCT ID:

NCT01328691

Start Date:

March 2011

Completion Date:

March 2011

Related Keywords:

  • Carcinoma, Renal Cell
  • Thrombus
  • Carcinoma, Renal Cell
  • thrombus
  • body mass index
  • grade
  • Carcinoma
  • Carcinoma, Renal Cell
  • Thrombosis

Name

Location